Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001628280-24-031841
Filing Date
2024-07-15
Accepted
2024-07-15 08:32:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 lenzthereapeutics424b3stic.htm 424B3 37154
2 lenz1a.jpg GRAPHIC 208038
  Complete submission text file 0001628280-24-031841.txt   325020
Mailing Address 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014
Business Address 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014 858-925-7000
LENZ Therapeutics, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-278393 | Film No.: 241115934
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)